D-dimer testing is important to aid in the exclusion of venous thromboembolic events (VTEs), including deep venous thrombosis and pulmonary embolism, and it may be used to evaluate suspected aortic dissection. D-dimer is produced upon activation of the coagulation system with the generation and subsequent degradation of cross-linked fibrin by plasmin. Many different assays for D-dimer testing are currently used in routine care. However, these tests are neither standardized nor harmonized. Consequently, only clinically validated assays and assay specific decision limits should be used for routine testing. For the exclusion of pulmonary embolism/deep vein thrombosis, age-adjusted cut-offs are recommend. Clinicians must be aware of the validated use of their hospital’s D-dimer assay to avoid inappropriate use of this biomarker in routine care.
MannKG. Biochemistry and physiology of blood coagulation. Thromb Haemost1999; 82: 165–174.
3.
MacfarlaneRG. An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature1964; 202: 498–499.
4.
DavieEWRatnoffOD. Waterfall sequence for intrinsic blood clotting. Science1964; 145: 1310–1312.
5.
MagerJJSchutgensREHaasFJ. The early course of D-dimer concentration following pulmonary artery embolisation. Thromb Haemost2001; 86: 1578–1579
6.
KarioKMatsuoTKobayashiH. Which factors affect high D-dimer levels in the elderly?Thromb Res1991; 62: 501–508.
7.
LeeAJFowkesGRLoweGD. Determinants of fibrin D-dimer in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol1995; 15: 1094–1097.
8.
TataruMCHeinrichJJunkerR. D-dimers in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction. Eur Heart J1999; 20: 1493–1502.
9.
RylattDBBlakeASCottisLE. An immunoassay for human D dimer using monoclonal antibodies. Thromb Res1983; 31: 767–778.
10.
DempfleCE. Validation, calibration, and specificity of quantitative D-dimer assays. Semin Vasc Med2005; 5: 315–320.
11.
EisenbergPRJaffeASStumpDC. Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysis. Circulation1990; 82: 1159–1168.
12.
SteinPDHullRDPatelKC. D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: A systematic review. Ann Intern Med2004; 140: 589–602.
13.
Di NisioMSquizzatoARutjesAWS. Diagnostic accuracy of D-dimer test for exclusion of venous thromboembolism: A systematic review. J Thromb Haemost. 2007; 52: 296–304.
14.
AppleFSJesseRLNewbyLK; National Academy of Clinical Biochemistry; IFCC Committee for Standardization of Markers of Cardiac Damage. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical issues for biochemical markers of acute coronary syndromes. Circulation2007; 115: e352–e355.
15.
GeersingGJTollDBJanssenKJ. Diagnostic accuracy and user-friendliness of 5 point-of-care D-dimer tests for the exclusion of deep vein thrombosis. Clin Chem2010; 56: 1758–1766.
16.
Clinical and Laboratory Standards Institute (CLSI). Quantitative D-dimer for the exclusion of venous thromboembolic disease: Approved guideline. CLSI document H59-A. Wayne, PA: CLSI, 2011.
17.
GeersingGJJanssenKJOudegaR. Excluding venous thromboembolism using point of care D-dimer tests in outpatients: A diagnostic meta-analysis. Br Med J2009; 339: b2990.
18.
CLSI. Collection, transport, and processing of blood specimens for testing plasma-based coagulation assays and molecular hemostasis assays: Approved guideline. 5th ed. CLSI document H21-A5. Wayne, PA: CLSI, 2008.
19.
LippiGCervellinGCasagrandaI. D-dimer testing for suspected venous thromboembolism in the emergency department. Consensus document of AcEMC, CISMEL, SIBioC, and SIMeL. Clin Chem Lab Med2014; 52: 621–628.
20.
BounameauxHCiraficiPde MoerlooseP. Measurement of D-dimer in plasma as diagnostic aid in suspected pulmonary embolism. Lancet1991; 337: 196–200.
21.
WellsPSAndersonDRRodgerM. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med2003; 349: 1227–1235.
22.
LagerstedtCIOlssonCGFagherBO. Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis. Lancet1985; 2: 515–518.
23.
PalaretiGCosmiBLegnaniC. PROLONG Investigators. D-dimer testing to determine the duration of anticoagulation therapy. N Engl J Med2006; 355: 1780–1789.
24.
VerhovsekMDouketisJDYiQ. Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism. Ann Intern Med2008; 149: 481–490.
25.
WadaHThachilJDi NisioM; The Scientific Standardization Committee on DIC of the International Society on Thrombosis Haemostasis. Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines. J Thromb Haemost2013; 11: 761–767.
26.
van der GraafFvan den BorneHvan der KolkM. Exclusion of deep venous thrombosis with D-dimer testing–comparison of 13 D-dimer methods in 99 outpatients suspected of deep venous thrombosis using venography as reference standard. Thromb Haemost2000; 83: 191–198.
27.
Di NisioM.SquizzatoARutjesAW. Diagnostic accuracy of D dimer test for exclusion of venous thromboembolism: A systematic review. J Thromb Haemost2007; 5: 296–304.
28.
GoodacreSSampsonFCSuttonAJ. Variation in the diagnostic performance of Ddimer for suspected deep vein thrombosis. QJM2005; 98: 513–527.
29.
Brill-EdwardsPLeeA. D-dimer testing in the diagnosis of acute venous thromboembolism. Thromb Haemost1999; 82: 688–694.
30.
DempfleCE. Use of D-dimer assays in the diagnosis of venous thrombosis. Semin Thromb Hemost2000; 26: 631–641.
31.
PerrierADesmaraisSMironMJ. Non-invasive diagnosis of venous thromboembolism in outpatients. Lancet1999; 353: 190–195.
32.
van BelleABüllerHRHuismanMV. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. JAMA2006; 295: 172–179.
33.
SöhneMKamphuisenPWvan MierloPJ. Diagnostic strategy using a modified clinical decision rule and D-dimer test to rule out pulmonary embolism in elderly in- and outpatients. Thromb Haemost2005; 94: 206–210.
34.
WellsPSAndersonDRRodgerM. Excluding pulmonary embolism at the bedside without diagnostic imaging: Management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and D-dimer. Ann Intern Med2001; 135: 98–107.
35.
WellsPSHirshJAndersonDR. Accuracy of clinical assessment of deep-vein thrombosis. Lancet1995; 345: 1326–1330.
36.
WickiJPernegerTVJunodAF. Assessing clinical probability of pulmonary embolism in the emergency ward: A simple score. Arch Intern Med2001; 161: 92–97.
37.
Le GalGRighiniMRoyPM. Prediction of pulmonary embolism in the emergency department: The revised Geneva score. Ann Intern Med2006; 144: 165–171.
38.
KlokFAMosICNijkeuterM. Simplification of the revised Geneva score for assessing clinical probability of pulmonary embolism. Arch Intern Med2008; 168: 2131–2136.
39.
JanssenKJvan der VeldeEFTen CateAJ. Optimisation of the diagnostic strategy for suspected deep-vein thrombosis in primary care. Thromb Haemost2011; 105: 154–160.
40.
OudegaRHoesAWTollDB. The value of clinical findings and D-dimer tests in diagnosing deep vein thrombosis in primary care. Semin Thromb Hemost2006; 32: 673–677.
41.
LucassenWGeersingGJErkensPM. Clinical decision rules for excluding pulmonary embolism: A meta-analysis. Ann Intern Med2011; 155: 448–460.
42.
GeersingGJZuithoffNPKearonC. Exclusion of deep vein thrombosis using the Wells rule in clinically important subgroups: Individual patient data meta-analysis. Br Med J2014; 348: g1340.
43.
BatesSMJaeschkeRStevensSM. American College of Chest Physicians. Diagnosis of DVT: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest2012; 141: e351S–e418S.
44.
National Institute for Health and Care Excellence. CG144 venous thromboembolic diseases: Two-level Wells score – templates for deep vein thrombosis and pulmonary embolism, http://guidance.nice.org.uk/CG144/TemplateWellsScore/doc/English (accessed 29 August 2013).
45.
KonstantinidesSTorbickiAAgnelliG.; Authors/Task Force Members.2014ESC Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Endorsed by the European Respiratory Society (ERS). Eur Heart J2014; 35: 3033–3069.
46.
LinkinsLABatesSMLangE. elective D-dimer testing for diagnosis of a first suspected episode of deep venous thrombosis. A randomized trial. Ann Intern Med2013; 158: 93–100.
47.
KruipMJSlobMJSchijenJH. Use of a clinical decision rule in combination with D-dimer concentration in diagnostic workup of patients with suspected pulmonary embolism: A prospective management study. Arch Intern Med2002; 162: 1631–1635.
48.
TickLWNijkeuterMKramerMH.; Christopher study investigators. High D-dimer levels increase the likelihood of pulmonary embolism. J Intern Med2008; 264: 195–200.
49.
DoumaRAKamphuisenPWHuismanMV. False normal results on multidetector row spiral computed tomography in patients with high clinical probability of pulmonary embolism. J Thromb Haemost2008; 6: 1978–1979.
50.
SteinPDFowlerSEGoodmanLR. PIOPED II investigators. Multidetector computed tomography for acute pulmonary embolism. N Engl J Med. 2006; 354: 2317–2327.
51.
RighiniMGoehringCBounameauxH. Effects of age on the performance of common diagnostic tests for pulmonary embolism. Am J Med2000; 109: 357–361.
52.
Di NisioMSohneMKamphuisenPW. D-dimer test in cancer patients with suspected acute pulmonary embolism.J Thromb Haemost2005; 3: 1239–1242.
53.
RighiniMLe GalGDe LuciaS. Clinical usefulness of D-dimer testing in cancer patients with suspected pulmonary embolism. Thromb Haemost2006; 95: 715–719.
54.
MironMJPerrierABounameauxH. Contribution of noninvasive evaluation to the diagnosis of pulmonary embolism in hospitalized patients. Eur Respir J1999; 13: 1365–1370.
55.
ChablozPReberGBoehlenF. TAFI antigen and D-dimer levels during normal pregnancy and at delivery. Br J Haematol2001; 115: 150–152.
56.
FrancalanciIComeglioPLiottaAA. D-dimer concentrations during normal pregnancy, as measured by ELISA. Thromb Res1995; 78: 399–405.
57.
RumleyAEmbersonJRWannametheeSG. Effects of older age on fibrin D-dimer, C-reactive protein, and other hemostatic and inflammatory variables in men aged 60–79 years. J Thromb Haemost2006; 4: 982–987.
58.
DoumaRAle GalGSöhneM. Potential of an age adjusted D-dimer cut-off value to improve the exclusion of pulmonary embolism in older patients: A retrospective analysis of three large cohorts. Br Med J2010; 340: c1475.
59.
SchoutenHJGeersingGJKoekHL. Diagnostic accuracy of conventional or age adjusted D-dimer cut-off values in older patients with suspected venous thromboembolism: Systematic review and meta-analysis. Br Med J2013; 346: f2492.
60.
RighiniMVan EsJDen ExterPL. Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study. JAMA2014; 311: 1117–1124.
61.
KlineJAWilliamsGWHernandez-NinoJ. D-dimer concentrations in normal pregnancy: New diagnostic thresholds are needed. Clin Chem2005; 51: 825–829.
62.
EpineyMBoehlenFBoulvainM. D-dimer levels during delivery and the postpartum. J Thromb Haemost2005; 3: 268–271.
63.
CarrierMLeeAYBatesSM. Accuracy and usefulness of a clinical prediction rule and D-dimer testing in excluding deep vein thrombosis in cancer patients. Thromb Res2008; 123: 177–183.
64.
LeeAYJulianJALevineMN. Clinical utility of a rapid whole-blood D-dimer assay in patients with cancer who present with suspected acute deep venous thrombosis. Ann Intern Med1999; 131: 417–423.
65.
ShimonyAFilionKBMottilloS. Metaanalysis of usefulness of D-dimer to diagnose acute aortic dissection. Am J Cardiol2011; 107: 1227–1234.
66.
SodeckGDomanovitsHSchillingerM. A D-dimer in ruling out acute aortic dissection: A systematic review and prospective cohort study. Eur Heart J2007; 28: 3067–3075.
67.
MarillKA. Serum D-dimer is a sensitive test for the detection of acute aortic dissection: A pooled meta-analysis.J Emerg Med2008; 34: 367–376.
68.
OldgrenJLinderRGripL. Coagulation activity and clinical outcome in unstable coronary artery disease. Arterioscler Thromb Vasc Biol2001; 21: 1059–1064.
69.
Tello-MontoliuAMarinFRoldanV. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: Implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels. J Intern Med2007; 262: 651–658.
70.
ChristerssonCOldgrenJBylockA. Early decrease in coagulation activity after myocardial infarction is associated with lower risk of new ischaemic events: Observations from the ESTEEM Trial. Eur Heart J2007; 28: 692–698.
71.
WatsonTShantsilaELipGY. Fibrin D-dimer levels and thromboembolic events in patients with atrial fibrillation. Int J Cardiol2007; 120: 123–124; author reply 125–126.
72.
HabaraSDoteKKatoM. Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation. Eur Heart J2007; 28: 2217–2222.
73.
LipGYNieuwlaatRPistersR. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The Euro Heart Survey on Atrial Fibrillation. Chest2010; 137: 263–272.
74.
SadanagaTSadanagaMOgawaS. Evidence that D-dimer levels predict subsequent thromboembolic and cardiovascular events in patients with atrial fibrillation during oral anticoagulant therapy. J Am Coll Cardiol2010; 55: 2225–2231.
75.
ChristerssonCWallentinLAnderssonU. D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation – observations from the ARISTOTLE trial. J Thromb Haemost2014; 12: 1404–1412.
76.
HijaziZOldgrenJSiegbahnA. Biomarkers in atrial fibrillation: A clinical review. Eur Heart J2013; 34: 1475–1480.
77.
TripodiA. D-dimer testing in laboratory practice. Clin Chem2011; 57: 1256–1262.
78.
DempfleCE. D-dimer testing and venous thromboembolism: Four view points. J Thromb Haemost2005; 3: 377–384.
